Vijaya Diagnostic Expands to Northeast, Acquires Guwahati-based Integrated Diagnostic Centre
NiveshIQ
NSE: VIJAYA · Healthcare
Vijaya Diagnostic Centre Ltd.
₹1,502.00▲ ₹3.20 (+0.21%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on VIJAYA. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Limited is a leading provider of diagnostic services in India, offering a wide range of laboratory and imaging services, including clinical pathology, microbiology, and magnetic resonance imaging (MRI) scans. The company's core business is driven by its laboratory services, which account for a significant portion of its revenue. Key revenue drivers for the company include its health checkups and home sample collection services, which have contributed to its growth in recent years. Recently, the company reported a 24.99% year-over-year increase in net sales to Rs 218.54 crore in June 2026, driven by strong demand for its diagnostic services. Vijaya Diagnostic Centre Limited has a strong competitive position in the Indian diagnostic services market, with a large netw
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹548.00 Cr +134.20% | ₹681.00 Cr +24.30% | ₹814.20 Cr +19.60% |
| EBITDA Margin | 40.15% | 40.09% | 43.94% |
| Net Profit | ₹120.00 Cr +172.70% | ₹144.00 Cr +20.00% | ₹172.98 Cr +20.10% |
| EPS | ₹11.63 | ₹13.97 | ₹16.81 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Vijaya Diagnostic Expands to Northeast, Acquires Guwahati-based Integrated Diagnostic Centre
Vijaya Diagnostic Centre acquires Arya Wellness for Rs 46 Cr, enters Assam
🔒
+ 3 more stories about Vijaya Diagnostic Centre Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹231 Cr, PAT ₹53 Cr, EPS ₹5.16, EBITDA margin 46.4%. Growth context: revenue QoQ +5.3%, PAT QoQ +10.8%. Street verdict: beat, revenue surprise +3.0%, PAT surprise +13.6%.
We note that management's commentary highlights new capacity additions and capex deployment as key near-term growth driv...
In FY26, the company reported revenue of ₹814 Cr, PAT of ₹173 Cr, an EBITDA margin of 43.9%, and EPS of ₹16.81, represen...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for VIJAYA
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track VIJAYA alongside your other holdings
Unlock full VIJAYA research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Vijaya Diagnostic Centre Ltd.?
NiveshIQ detects active intelligence signals for Vijaya Diagnostic Centre Ltd. (VIJAYA) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Vijaya Diagnostic Centre Ltd.?
Vijaya Diagnostic Centre Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,311,933.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.